Effect of intravenous calcium administration on gentamicin-induced nephrotoxicosis in ponies

American Journal of Veterinary Research

Volumn 59, Issue 8, 1998, Pages 1055-1062

  Brashier, Michael K ^a,b   Geor, Raymond J ^a,c   Ames, Trevor R ^a   O'Leary, Terrance P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GENTAMICIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; HISTOPATHOLOGY; HORSE; NEPHROTOXICITY; NONHUMAN; URINALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; CALCIUM; CALCIUM GLUCONATE; CREATININE; ELECTROLYTES; FEMALE; GENTAMICINS; GLYCOSURIA; HORSES; INFUSIONS, INTRAVENOUS; KIDNEY; NEPHROSIS; URINALYSIS; URINE;

ANIMALIA; EQUUS CABALLUS;

EID: 0031904486     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Watling SM, Dasta JF. Aminoglycoside dosing considerations in intensive care unit patients. Ann Pharmacother 1993;27:351-357.
2. Gilbert DN. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991;35:399-405.
3. Zaske DE. Aminoglycosides. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics. 3rd ed. Vancouver, Wash: Applied Therapeutics, 1992;14.1-14.47.
4. Tulkens PM. Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin. J Antimicrob Chemother 1991;27(Suppl C):49-61.
5. Kapusnik JE, Hackbarth CJ, Chambers HF, et al Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia (published erratum appears in J Infect Dis 1988;158:911). J Infect Dis 1988;158:7-12.
6. Prins JM, Buller HR, Kuijper EJ, et al. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993; 341:335-339.
7. Zhanel GG, Ariano RE. Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity? Renal Fail 1992; 14:1-9.
8. Bennett WM, Elliott WC, Houghton DC, et al. Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loading. Antimicrob Agents Chemother 1982;22:508-512.
9. Fukuda Y, Eklof AC, Malmborg AS, et al. Calcium supplementation and thyroid hormone protect against gentamicin-induced inhibition of proximal tubular Na+, K(+)-ATPase activity and other renal functional changes. Acta Physiol Scand 1992;145:93-98.
10. Cronin R, Inman L, Eche T, et al. Effect of thyroid hormone on gentamicin accumulation in rat proximal tubule lysosomes. Am J Physiol 1989;257:F86-F91.
11. Swan SK, Gilbert DN, Kohlhepp SJ, et al. Pharmacologic limits of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity. Antimicrob Agents Chemother 1993;37: 347-348.
12. Kishore BK, Ibrahim S, Lambricht P, et al. Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats. J Pharmacol Exp Ther 1992;262:424-432.
13. Schumacher J, Wilson RC, Spano JS, et al. Effect of diet on gentamicin-induced nephrotoxicosis in horses. Am J Vet Res 1991; 52:1274-1278.
14. Oukessou M, Toutain PL. Effect of dietary nitrogen intake on gentamicin disposition in sheep. J Vet Pharmacol Ther 1992;15: 416-420.
15. Park GD, Spector R, Kitt TM. Effect of dietary protein on renal tubular clearance of drugs in humans. Clin Pharmacokinet 1989;17:441-451.
16. Ott EA, Baker JP, Hintz HF, et al. Nutrient requirements of horses. 5th ed. Washington, DC: National Academy Press, 1989;10.
17. Sawchuck RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. J Pharmacokinet Biopharm 1976;4:183-199.
18. Sawchuk RJ, Zaske DE, Cipolle RJ, et al. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther 1977;21:362-369.
19. Haddad NS, Pedersoli WM, Ravis WR, et al. Pharmacokinetics of gentamicin at steady-state in ponies: serum, urine, and endometrial concentrations. Am J Vet Res 1985;46:1268-1271.
20. Haddad NS, Pedersoli WM, Ravis WR, et al. Combined pharmacokinetics of gentamicin in pony mares after a single intravenous and intramuscular administration. Am J Vet Res 1985;46: 2004-2007.
21. Jameson JP, Lewis JA. Three-point versus two-point method for early individualization of aminoglycoside doses. Ann Pharmacother 1991;25:653-657.
22. Torres MJ, Kern JW, Gill MA, et al. Comparison of serum sampling methods for estimating gentamicin pharmacokinetic variables. Clin Pharm 1983;2:353-355.
23. Duncan RJ, Prasse KW. Urinary system. Veterinary laboratory medicine: clinical pathology. 1st ed. Ames, Iowa: The Iowa State University Press, 1977;99-115.
24. Bradley M, Schumann GB. Examination of urine. In: Henry JB, ed. Clinical diagnosis and management by laboratory methods. 17th ed. Philadelphia: WB Saunders Co, 1984;405-409.
25. Divers TJ. Equine renal system. In: Smith BP, ed. Large animal internal medicine. 2nd ed. St Louis: Mosby, 1996;953-974.
26. Powell SH, Thompson WL, Luthe MA, et al. Once daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. J Infect Dis 1983;147:918-932.
27. Riviere JE, Coppoc GL, Hinsman EJ, et al. Species dependent gentamicin pharmacokinetics and nephrotoxicity in the young horse. Fund Appl Toxicol 1983;3:448-457.
28. Parsons TD, Obaid AL, Salzberg BM. Aminoglycoside antibiotics block voltage-dependent calcium channels in intact vertebrate nerve terminals. J Gen Physiol 1992;99:491-504.
29. Pickrell JA, Oehme FW, Cash WC. Ototoxicity in dogs and cats. Semin Vet Med Surg Small Anim 1993;8:42-49.
30. Nonclercq D, Wrona S, Toubeau G, et al. Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study. Renal Fail 1992;14:507-521.
31. Gilbert DN, Houghton DC, Bennett WM, et al. Reversibility of gentamicin nephrotoxicity in rats: recovery during continuous drug administration. Proc Soc Exp Biol Med 1979;160:99-103.
32. Olbricht CJ, Fink M, Gutjahr E. Alterations in lysosomal enzymes of the proximal tubule in gentamicin nephrotoxicity. Kidney Int 1991;39:639-646.
33. Greco DS, Turnwald GH, Adams R, et al. Urinary g-glutamyl transpeptidase activity in dogs with gentamicin-induced nephrotoxicity. Am J Vet Res 1985;46:2332-2335.
34. Hinchcliff KW, McGuirk SM, MacWilliams PS, et al. Phenolsulfonphthalein pharmacokinetics and renal morphologic changes in adult pony mares with gentamicin-induced nephrotoxicosis. Am J Vet Res 1989;50:1848-1853.
35. Sweeney RW, Divers TJ, Rossier Y. Disposition of gentamicin administered intravenously to horses with sepsis. J Am Vet Med Assoc 1992;200:503-506.
36. Riviere JE, Traver DS, Coppoc GL. Gentamicin toxic nephropathy in horses with disseminated bacterial infection. J Am Vet Med Assoc 1982;180:648-651.
37. Sojka JE, Brown SA. Pharmacokinetic adjustment of gentamicin dosing in horses with sepsis. J Am Vet Med Assoc 1986;189: 784-789.
38. Spiegel DM, Shanley PF, Molitoris BA. Mild ischemia predisposes the S3 segment to gentamicin toxicity. Kidney Int 1990;38: 459-464.
39. Zager RA. Gentamicin nephrotoxicity in the setting of acute renal hypoperfusion. Am J Physiol 1988;254:F574-F581.
40. Zager RA. Endotoxemia, renal hypoperfusion, and fever: interactive risk factors for aminoglycoside and sepsis-associated acute renal failure. Am J Kidney Dis 1992;20:223-230.
41. Auclair P, Tardif D, Beauchamp D, et al. Prolonged endotoxemia enhances the renal injuries induced by gentamicin in rats. Antimicrob Agents Chemother 1990;34:889-895.
42. Tardif D, Beauchamp D, Bergeron MG. Influence of endotoxin on the intracortical accumulation kinetics of gentamicin in rats. Antimicrob Agents Chemother 1990;34:576-580.
43. Zaske DE, Cipolle RJ, Rotschafer JC, et al. Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations. Antimicrob Agents Chemother 1982;21:407-411.
44. Hinchcliff KW, McGuirk SM, MacWilliams PS. Gentamicin nephrotoxicity, in Proceedings. Annu Meet Am Assoc Equine Pract 1987;33:67-75.
45. Thomson AH, Campbell KC, Kelman AW. Evaluation of six gentamicin nomograms using a Bayesian parameter estimation program. Ther Drug Monit 1990;12:258-263.
46. Perkins MW. Failure of a nomogram to achieve target aminoglycoside concentrations (letter). Br J Clin Pharmacol 1990;29: 495-496.
47. Kacew S, Bergeron MG. Pathogenic factors in aminoglycoside-induced nephrotoxicity. Toxicol Lett 1990;51:241-259.
48. Robert S, Zarowitz BJ. Is there a reliable index of glomerular filtration rate in critically ill patients? Ann Pharmacother 1991; 25:169-177.
49. Zarowitz BJ, Robert S, Peterson EL. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients. Ann Pharmacother 1992;26:1205-1210.
50. Humes HD. Aminoglycoside nephrotoxicity. Kidney Int 1988;33:900-911.
51. Farese RV, Bidot-Lopez P, Sabir A, et al. Parathyroid hormone acutely increases polyphosphoinositides of the rabbit kidney cortex by a cycloheximide-sensitive process. J Clin Invest 1980;65: 1523-1526.
52. Ernest S. Model of gentamicin-induced nephrotoxicity and its amelioration by calcium and thyroxine. Med Hypotheses 1989;30: 195-202.
53. Rasmussen H, Kojima I, Apfeldorf W, et al. Cellular mechanism of hormone action in the kidney: messenger function of calcium and cAMP. Kidney Int 1986;29:90-97.
54. Elliot WC, Patchin DS, Jones DB. Effect of parathyroid hormone activity on gentamicin nephrotoxicity. J Lab Clin Med 1987; 109:48-54.
55. Guyton AC. Textbook of medical physiology. 8th ed. Philadelphia: WB Saunders Co, 1991;877.
56. Bourdeau JE, Bouillon R, Zikos D, et al. Renal responses to calcium deprivation in young rabbits. Miner Electrolyte Metab 1988; 14:150-157.
57. Humes HD, Sastrasinh M, Weinberg JM. Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity. J Clin Invest 1984;73:134-147.
58. Hancock REW. Aminoglycoside uptake and mode of action with special reference to streptomycin and gentamicin. J Antimicrob Chemother 1981;8:249-276.
59. Jackson GG, Lolans VT, Daikos GL. The inductive role of ionic binding in the bactericidal and postexposure effects of aminoglycoside antibiotics with implications for dosing. J Infect Dis 1990;162:408-413.
60. Daikos GL, Lolans VT, Jackson GG. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with the meaning for optimal clinical use. Antimicrob Agents Chemother 1991;35: 117-123.
61. Hancock RE, Farmer SW, Li ZS, et al. Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli. Antimicrob Agents Chemother 1991;35:1309-1314.
62. Edson RS, Terrell CL. The aminoglycosides. Mayo Clin Proc 1991;66:1158-1164.